Prostate Cancer Parameters for Patients Receiving Proton Treatment

Withdrawn before enrolling

Conditions studied: Prostate Cancer

In brief

To prospectively collect data from patients treated with proton therapy for prostate cancer using the IUHPTC technique for the evaluation of toxicity and efficacy of this treatment technique.

Key facts

Study ID

NCT02110849

Run by

Indiana University

People needed

0

Starts

2013-01-01

Expected to finish

2016-04-01

Last updated by the study team

2016-04-07

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Subjects must have histologically or cytologically confirmed adenocarcinoma of the prostate and are scheduled to receive proton radiation treatment at IUHPTC.
• Subjects with any stage or grade of tumor will be allowed including proton salvage therapy in the context of a rising PSA after surgery and a negative metastatic work-up.
• Prior use of Lupron therapy or a similar agent is allowed. Use of Lupron or similar agent must be for ≤ 6 months prior to enrollment.
• Use of Casodex and agents in the same drug class is allowed. Age is ≥ 18 years at the time of consent.
• The ability to understand and willingness to sign an informed consent and authorization for the release of health information.

You may not qualify if…

• Evidence of distant metastases at the time of enrollment.

Where it is running

• Iu Health Proton Therapy Center — Bloomington, Indiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.